Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non-Current Assets: 2013-2020

Historic Other Non-Current Assets for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $1.3 million.

  • Larimar Therapeutics' Other Non-Current Assets changed negligibly% to $1.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $90,000 for FY2019, which is 57.89% up from last year.
  • Larimar Therapeutics' Other Non-Current Assets amounted to $1.3 million in Q3 2020, which was down 0.00% from $1.3 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Other Non-Current Assets registered a high of $1.3 million during Q1 2019, and its lowest value of $57,000 during Q3 2017.
  • Moreover, its 3-year median value for Other Non-Current Assets was $1.3 million (2020), whereas its average is $793,364.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 35.11% in 2016, then skyrocketed by 2,249.12% in 2019.
  • Larimar Therapeutics' Other Non-Current Assets (Quarterly) stood at $61,000 in 2016, then fell by 6.56% to $57,000 in 2017, then remained steady at $57,000 in 2018, then spiked by 57.89% to $90,000 in 2019, then remained steady at $1.3 million in 2020.
  • Its last three reported values are $1.3 million in Q3 2020, $1.3 million for Q2 2020, and $1.3 million during Q1 2020.